Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer

Brachytherapy

Volumn 10, Issue 3, 2011, Pages 253-259

  Chan, Michael D ^a   Dupuy, Damian E ^a   Mayo Smith, William W ^a   Ng, Thomas ^a   DiPetrillo, Thomas A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

HDR brachytherapy; Lung cancer; Radiofrequency ablation

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CATHETER; CLINICAL ARTICLE; DYSPNEA; EMPYEMA; FOLLOW UP; HUMAN; LUNG HEMORRHAGE; LUNG NON SMALL CELL CANCER; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; RADIOGRAPHY; RETROSPECTIVE STUDY; TOXICITY; TUBE;

AGED; BRACHYTHERAPY; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 79955165079     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.07.002     Document Type: Article

References (18)

1. Fernando H.C., De Hoyos A., Landreneau R.J., et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005, 129:639-644.
2. Ambrogi M.C., Lucchi M., Dini P., et al. Percutaneous radiofrequency ablation of lung tumours: Results in the mid-term. Eur J Cardiothorac Surg 2006, 30:177-183.
3. de Baere T., Palussiere J., Auperin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: Prospective evaluation. Radiology 2006, 240:587-596.
4. Dupuy D.E., DiPetrillo T., Gandhi S., et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006, 129:738-745.
5. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622. discussion 622-613.
6. Shennib H., Bogart J., Herndon J.E., et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg 2005, 129:813-818.
7. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005, 63:1010-1015.
8. Voynov G., Heron D.E., Lin C.J., et al. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 2005, 4:278-285.
9. Lee W., Daly B.D., DiPetrillo T.A., et al. Limited resection for non-small cell lung cancer: Observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 2003, 75:237-242. discussion 242-233.
10. Rose S.C., Thistlethwaite P.A., Sewell P.E., et al. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 2006, 17:927-951. quiz 951.
11. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998, 40:149-154.
12. Hiraki T., Sakurai J., Tsuda T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: Evaluation based on a preliminary review of 342 tumors. Cancer 2006, 107:2873-2880.
13. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000, 48:1015-1024.
14. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.
15. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998, 42:1-9.
16. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65:640-645.
17. Choi N.C., Kanarek D.J. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 1994, 10(Suppl. 1):S219-S230.
18. Lee J.M., Jin G.Y., Goldberd S.N., et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004, 230:125-134.